Skip to content
STESteris

What Is STE Fair Value?

Steris (STE) fair value estimate using multiple valuation models, updated daily.

As of July 16, 2026, Steris (STE) has a composite fair value estimate of $143.43 based on four valuation models: DCF (35% weight), Graham Number (25% weight), PEG (25% weight), and DDM (15% weight). The current market price is $211.46, suggesting the stock is overvalued by 32.2%.

Data as of July 16, 2026 (today)

Composite Fair Value

Overvalued4 of 4 models

$143.43

vs. current price of $211.46(-32.2%)

Undervalued$143.43Overvalued
$211.46

How Is STE Fair Value Calculated?

Four independent models estimate what STE is worth. Each uses different inputs and assumptions. The composite blends them by weight.

STE Intrinsic Value

Forward-looking models based on future cash flows

DCF (Discounted Cash Flow)

35% weight

Estimates how much cash the company will generate over the next 10 years, then calculates what all that future cash is worth in today's dollars. Includes a 15% safety cushion. Try the standalone DCF calculator →

$178.33

-15.7%

Overvalued

Inputs used

FCF: 837.3MGrowth: 9.4%Discount: 9%

DDM (Dividend Discount Model)

15% weight

If a company pays you dividends, this model asks: how much are all those future dividend payments worth today? Only works for stocks that pay dividends. Try the intrinsic value calculator →

$54.37

-74.3%

Overvalued

Inputs used

Dividend: $2.52/yrReq. Return: 10%Growth: 4.7%

STE Fair Value

Current fundamentals: earnings, assets, and growth rate

Graham Number (Value Investing)

25% weight

Created by legendary investor Benjamin Graham. It looks at two things: how much the company earns (EPS) and what its assets are worth (Book Value), then calculates the maximum price a careful investor should pay. Try the fair value calculator →

$135.79

-35.8%

Overvalued

Inputs used

EPS: $11.16Book Value: $73.45

PEG (Price/Earnings to Growth)

25% weight

Checks if you're paying a fair price for the company's growth. A fast-growing company deserves a higher price than a slow one. This model finds the right price based on how fast earnings are growing.

$111.58

-47.2%

Overvalued

Inputs used

EPS: $11.16Growth: 9.4%

What If You Change the Assumptions?

Drag the sliders to test different scenarios. Tap the ? buttons to learn what each input means.

Your DCF Fair Value

$178.33Overvalued

Current price $211.46 is 15.7% above this estimate

CheapFair ValueExpensive
9.4%
0.0%30.0%
9.1%
6.0%15.0%
2.5%
1.0%4.0%
15.0%
0.0%50.0%
View 10-year cash flow projections
YearProjected FCF (Free Cash Flow)Present Value
Year 1$916.3M$840.2M
Year 2$1.00B$843.1M
Year 3$1.10B$846.1M
Year 4$1.20B$849.0M
Year 5$1.31B$852.0M
Year 6$1.44B$855.0M
Year 7$1.57B$858.0M
Year 8$1.72B$861.0M
Year 9$1.88B$864.0M
Year 10$2.06B$867.0M
Terminal Value$32.26B$13.56B

What Are STE's Key Financial Metrics?

Earnings & Growth

Current Price

$211.46

EPS (TTM)

$8.04

Forward P/E

17.4

Profit Margin

13.2%

Cash & Balance Sheet

Free Cash Flow

837.3M

EBITDA

1.6B

Book Value

$73.45

Total Debt

2.1B

What Do Analysts Say About STE?

Low

$225.00

Average

$256.86

High

$280.00

Upside

+21.5%

Current $211.46Avg Target $256.867 analysts

STE Fair Value FAQ

What is the fair value of STE?

Based on our composite model (DCF 35%, Graham 25%, PEG 25%, DDM 15%), STE's estimated fair value is $143.43. The stock is currently trading at $211.46, which makes it overvalued by our analysis.

How is STE's fair value calculated?

We use four valuation methods: Discounted Cash Flow (DCF), Graham Number, PEG-based Fair Value, and Dividend Discount Model (for dividend-paying stocks). The composite score weights DCF at 35%, Graham and PEG at 25% each, and DDM at 15%. When a model can't be applied, its weight is redistributed proportionally.

Is STE overvalued or undervalued?

Based on our analysis, STE is overvalued. The current price of $211.46 is 32.2% above our estimated fair value of $143.43.

What do Wall Street analysts say about STE?

7 analysts cover Steris with a consensus rating of "." The average price target is $256.86, ranging from $225.00 to $280.00. This implies 21.5% upside from the current price.